Sharpe ratio
0.93Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+22.70%1Y Absolute Return
+0.07%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - GrowthFund 5Y annualised return | ₹10,86,593 | ₹7,32,612 | ₹3,53,981 | +15.78% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.17
₹1 Lakh since launch₹1.17 Lakh
Fund age6.0 yrs
Fund information
Scheme code148555
ISININF754K01LV5
BenchmarkMSCI India Domestic & World HC 45 Index
CategoryOther Scheme - Index Funds
Expense ratio0.55%
Exit loadNil
Minimum SIP₹100 SIP
Return comparison
13th / 1122 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +205.36% | — | — |
| 3M | +27.19% | — | — |
| 6M | +35.11% | — | — |
| 1Y | +22.70% | — | +1.74% |
| 3Y | +21.90% | — | +9.75% |
| 5Y | +15.78% | — | +8.73% |
| Since Launch | +17.30% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.38Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
11.93%How much the fund’s returns fluctuate over time.
Moderate volatility
Returns can move up and down noticeably.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
1.06How well the fund rewarded investors relative to its biggest decline.
Excellent
Excellent balance between returns and drawdowns.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 47 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.3% |
| Eli Lilly Forgn. Eq (LLY) | Healthcare | Foreign - Equity | 6.43% |
| Divi's Laboratories Ltd | Healthcare | Equity | 6.07% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.69% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.89% |
| Cipla Ltd | Healthcare | Equity | 4.69% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.61% |
| Johnson & Johnson Ltd. Forgn. Eq (JNJ) | Healthcare | Foreign - Equity | 4.3% |
| Laurus Labs Ltd | Healthcare | Equity | 4.02% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 3.63% |
Fund management
AM
Amit Vora
Since 2021 · Antique Stock Broking Ltd, D.E. Shaw India Securities Pvt. Ltd, Derivium Tradition Securities (India) Pvt Ltd, Tower Capital & Securities Pvt Ltd and B&K Securities
Mr. Vora has done B.Com from University of Mumbai
BH
Bhavesh Jain
Since 2021 · Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Mr. Jain is a MMS (Finance) from Mumbai University.
MA
Manasi Jalgaonkar
Since 2026 · Prior to joining the Edelweiss AMC, she was associated with ICICI AMC and Randstad.
PGDM, BMS
Compare similar funds
No comparable category funds are available yet.
Summary
A high-risk other scheme - index funds fund. Ahead of its category average over 3Y by 12.1 points. Healthcare makes up 100% — trouble in that sector hits the whole fund.
Strengths
- Ahead of its category average over 3Y by 12.1 points.
- Losses and swings stayed contained — worst fall -16.3%, volatility 11.9%.
- Same fund manager for 6+ years — the strategy has not chopped and changed.
- Ranks 13 of 1122 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 5+ years horizon to ride out its high risk level.
- Good fit for SIPs — spreading purchases smooths out 11.9% volatility.
Risk drivers
- Healthcare makes up 100% — trouble in that sector hits the whole fund.